ALLERGIC RHINOCONJUNCTIVITIS

Clinical trials for ALLERGIC RHINOCONJUNCTIVITIS explained in plain language.

Never miss a new study

Get alerted when new ALLERGIC RHINOCONJUNCTIVITIS trials appear

Sign up with your email to follow new studies for ALLERGIC RHINOCONJUNCTIVITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 2

New tablet could tame dust mite misery

Disease control Recruiting now

This study is testing a daily dissolving tablet designed to reduce allergy symptoms caused by house dust mites. It will involve 300 Chinese participants, aged 12-65, who have allergic rhinitis or conjunctivitis, with or without asthma. The goal is to see if the tablet is better t…

Matched conditions: ALLERGIC RHINOCONJUNCTIVITIS

Phase: PHASE3 • Sponsor: ALK-Abelló A/S • Aim: Disease control

Last updated Apr 02, 2026 05:12 UTC

ALLERGIC RHINOCONJUNCTIVITIS

Get alerted when new ALLERGIC RHINOCONJUNCTIVITIS trials appear

New tablet could tame dust mite misery